New Delhi: The approval for Bharat Biotech’s Covaxin for use in the 2-18 years age group may take time before it is made available for people.
The Drugs Controller General of India (DCGI) is carefully examining the recommendation by the expert panel and evaluating several factors, Business Standard reported on Wednesday.
Last week, the panel had recommended the usage of Covaxin for children as young as two. The final approval for 2-18 years old is under expert opinion and evaluation.
The DCGI will hold discussions with the health minister, PMO, and Bharat Biotech before granting EUA to Covaxin, the report quoted sources as saying.
Bhubaneswar: The Odisha government decisive steps toward the early operationalisation of two crucial medical colleges… Read More
Mumbai: The date -- June 29, 2024. The venue – Kensington Oval, Bridgetown (Barbados). The occasion… Read More
Mumbai: Amid the ongoing legal feud with stepdaughter Esha Verma, ‘Anupamaa’ actress Rupali Ganguly recently… Read More
Bhubaneswar: At least 35 pilgrims from Odisha’s Balasore sustained injuries as the bus in which… Read More
Chennai: A senior Chennai police officer, serving as Joint Commissioner, has been suspended after two… Read More
Chennai: Eminent actor Kamal Haasan is set to become a Rajya Sabha Member of Parliament… Read More
This website uses cookies.
